398 related articles for article (PubMed ID: 17299437)
1. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
[TBL] [Abstract][Full Text] [Related]
2. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH
Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Br J Clin Pharmacol; 2007 Jul; 64(1):57-66. PubMed ID: 17298481
[TBL] [Abstract][Full Text] [Related]
4. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
6. Diuretic-gene interaction and the risk of myocardial infarction and stroke.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH
Pharmacogenomics J; 2007 Oct; 7(5):346-52. PubMed ID: 17189961
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the renin--angiotensin system, use of renin--angiotensin system inhibitors and the risk of myocardial infarction.
Maitland-van der Zee AH; van Wieren-de Wijer DB; de Boer A; Kroon AA; de Leeuw PW; Schiffers P; Janssen RG; Psaty BM; van Duijn CM; Stricker BH; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):208-14. PubMed ID: 21163865
[TBL] [Abstract][Full Text] [Related]
8. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.
Ravn LS; Benn M; Nordestgaard BG; Sethi AA; Agerholm-Larsen B; Jensen GB; Tybjaerg-Hansen A
Pharmacogenet Genomics; 2008 Jun; 18(6):525-33. PubMed ID: 18496132
[TBL] [Abstract][Full Text] [Related]
9. Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients.
Bis JC; Smith NL; Psaty BM; Heckbert SR; Edwards KL; Lemaitre RN; Lumley T; Rosendaal FR
Am J Hypertens; 2003 Dec; 16(12):1011-7. PubMed ID: 14643574
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
11. [The effect of the angiotensinogen M235T and the angiotensin-converting enzyme I/D polymorphisms on arterial hypertension and other cardiovascular risk factors].
Pamies Andreu E; Palmero Palmero C; García Lozano R; Stiefel García-Junco P; Miranda Guisado ML; Martín Sanz V; Villar Ortiz J; Núñez Roldán A; Carneado de la Fuente J
Med Clin (Barc); 1999 Jul; 113(5):164-8. PubMed ID: 10480138
[TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition to neurological symptoms in lacunar infarction.
Zhang JH; Kohara K; Yamamoto Y; Nakura J; Tabara Y; Fujisawa M; Katagi R; Miki T
Cerebrovasc Dis; 2004; 17(4):273-9. PubMed ID: 15026609
[TBL] [Abstract][Full Text] [Related]
13. [Meta-analysis on the association of AGT M235T polymorphism and essential hypertension in Chinese population].
Chen P; Jiang YF; Cheng K
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):711-4. PubMed ID: 14521795
[TBL] [Abstract][Full Text] [Related]
14. [A molecular variant of angiotensinogen gene is associated with myocardial infarction in Chinese].
Chen D; Zhang M; Fan W; Shi H; Li Y; Chen Q; Zhang J; Gu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Jun; 15(3):133-5. PubMed ID: 9621117
[TBL] [Abstract][Full Text] [Related]
15. Genotypic interactions of renin-angiotensin system genes in myocardial infarction.
Araújo MA; Goulart LR; Cordeiro ER; Gatti RR; Menezes BS; Lourenço C; Silva HD
Int J Cardiol; 2005 Aug; 103(1):27-32. PubMed ID: 16061119
[TBL] [Abstract][Full Text] [Related]
16. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients.
van den Born BJ; van Montfrans GA; Uitterlinden AG; Zwinderman AH; Koopmans RP
J Hypertens; 2007 Nov; 25(11):2227-33. PubMed ID: 17921816
[TBL] [Abstract][Full Text] [Related]
17. [Association between hypertensive cerebrovascular stroke and renin-angiotensin system gene polymorphism from Chinese cohort in Shanghai].
Wei X; Wang G; Jiang C; Li D; Zhao G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):256-8. PubMed ID: 10932009
[TBL] [Abstract][Full Text] [Related]
18. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J
J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
